000 01678 a2200457 4500
005 20250515072418.0
264 0 _c20071107
008 200711s 0 0 eng d
022 _a0022-3042
024 7 _a10.1111/j.1471-4159.2007.04706.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWoster, Andrew P
245 0 0 _aDifferential ability of a thiazolidinedione PPARgamma agonist to attenuate cytokine secretion in primary microglia and macrophage-like cells.
_h[electronic resource]
260 _bJournal of neurochemistry
_cOct 2007
300 _a67-76 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAnilides
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aAnti-Inflammatory Agents
_xpharmacology
650 0 4 _aCell Differentiation
_xdrug effects
650 0 4 _aCell Line, Tumor
650 0 4 _aCells, Cultured
650 0 4 _aCytokines
_xmetabolism
650 0 4 _aHumans
650 0 4 _aI-kappa B Proteins
_xmetabolism
650 0 4 _aLigands
650 0 4 _aLipopolysaccharides
_xpharmacology
650 0 4 _aMacrophages
_xdrug effects
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMicroglia
_xdrug effects
650 0 4 _aMonocytes
_xdrug effects
650 0 4 _aNF-KappaB Inhibitor alpha
650 0 4 _aPPAR gamma
_xagonists
650 0 4 _aRosiglitazone
650 0 4 _aTetradecanoylphorbol Acetate
_xpharmacology
650 0 4 _aThiazolidinediones
_xpharmacology
700 1 _aCombs, Colin K
773 0 _tJournal of neurochemistry
_gvol. 103
_gno. 1
_gp. 67-76
856 4 0 _uhttps://doi.org/10.1111/j.1471-4159.2007.04706.x
_zAvailable from publisher's website
999 _c17111668
_d17111668